BR112013016135A2 - preparação hemostática contendo um extrato de cibotium barometz. - Google Patents

preparação hemostática contendo um extrato de cibotium barometz.

Info

Publication number
BR112013016135A2
BR112013016135A2 BR112013016135A BR112013016135A BR112013016135A2 BR 112013016135 A2 BR112013016135 A2 BR 112013016135A2 BR 112013016135 A BR112013016135 A BR 112013016135A BR 112013016135 A BR112013016135 A BR 112013016135A BR 112013016135 A2 BR112013016135 A2 BR 112013016135A2
Authority
BR
Brazil
Prior art keywords
extract
preparation containing
cibotium barometz
hemostatic preparation
hemostatic
Prior art date
Application number
BR112013016135A
Other languages
English (en)
Inventor
Ming Xintian
Wang Yi-Lan
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Publication of BR112013016135A2 publication Critical patent/BR112013016135A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/41—Crassulaceae (Stonecrop family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287—Chrysanthemum, e.g. daisy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0038—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BR112013016135A 2010-12-22 2011-12-16 preparação hemostática contendo um extrato de cibotium barometz. BR112013016135A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/975,589 US10022410B2 (en) 2010-12-22 2010-12-22 Hemostatic preparation containing an extract of golden moss
PCT/US2011/065326 WO2012087774A1 (en) 2010-12-22 2011-12-16 Hemostatic preparation containing an extract of golden moss

Publications (1)

Publication Number Publication Date
BR112013016135A2 true BR112013016135A2 (pt) 2018-07-10

Family

ID=45478524

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013016135A BR112013016135A2 (pt) 2010-12-22 2011-12-16 preparação hemostática contendo um extrato de cibotium barometz.

Country Status (11)

Country Link
US (2) US10022410B2 (pt)
EP (1) EP2654764B1 (pt)
JP (1) JP6000976B2 (pt)
CN (1) CN103260633B (pt)
AU (1) AU2011349659B2 (pt)
BR (1) BR112013016135A2 (pt)
CA (1) CA2822251A1 (pt)
ES (1) ES2572946T3 (pt)
RU (1) RU2581918C2 (pt)
TW (2) TW201722449A (pt)
WO (1) WO2012087774A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8815832B2 (en) 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
US9149529B2 (en) * 2012-10-24 2015-10-06 Orthovita, Inc. Stable compositions containing thrombin and methods for preparation and use thereof
US20150130723A1 (en) * 2013-11-08 2015-05-14 Microsoft Corporation Two step content selection with trajectory copy
IL249725A0 (en) 2016-12-22 2017-03-30 Omrix Biopharmaceuticals Ltd A hemostatic preparation containing an anion exchanger and a calcium salt
US11007299B2 (en) 2017-11-08 2021-05-18 Ethicon, Inc. Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery
CN108310448B (zh) * 2018-02-07 2021-03-02 广州迈普再生医学科技股份有限公司 一种流体明胶止血材料的制备方法
US20230022609A1 (en) * 2021-07-14 2023-01-26 Shaanxi Panlong Pharmaceutical Co., Ltd. Polygoni milletii rhizome compositions and methods of preparing the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4891359A (en) * 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
US6045570A (en) 1997-02-11 2000-04-04 Biointerventional Corporation Biological sealant mixture and system for use in percutaneous occlusion of puncture sites and tracts in the human body and method
DE19844836A1 (de) 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
US6652840B1 (en) * 2001-02-21 2003-11-25 Terence Prevendar Bleeding control and healing aid compositions and methods of use
US7923431B2 (en) 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
RU2226406C1 (ru) 2002-07-22 2004-04-10 Шканакин Лев Геннадьевич Гемостатическая, антисептическая и ранозаживляющая губка
CN1539508A (zh) 2003-10-27 2004-10-27 武汉锐力科技有限公司 创面修复敷料基质、敷料及制备工艺
KR20070046093A (ko) 2004-07-09 2007-05-02 훼로산 아크티에 셀스카브 히알루론산을 포함하는 지혈 조성물
US20090227689A1 (en) 2007-03-05 2009-09-10 Bennett Steven L Low-Swelling Biocompatible Hydrogels
CN101156935A (zh) 2007-03-12 2008-04-09 北京联合伟华药业有限公司 治疗偏头痛的植物活性成分组合物及其制备方法和应用
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US8445545B2 (en) 2008-05-07 2013-05-21 Nicholas DeSica Pharmaceutical composition, method of preparation and methods of treating aches/pains
CN101317916B (zh) 2008-07-22 2010-12-08 朱安福 一种治疗崩漏的药剂及其制备方法
CN102307600B (zh) 2008-12-11 2015-11-25 巴克斯特国际公司 以纤维蛋白原和硫酸化多糖为基础的制剂

Also Published As

Publication number Publication date
ES2572946T3 (es) 2016-06-03
TW201722449A (zh) 2017-07-01
AU2011349659A1 (en) 2013-07-18
US10022411B2 (en) 2018-07-17
JP2014501260A (ja) 2014-01-20
CN103260633B (zh) 2018-10-30
RU2581918C2 (ru) 2016-04-20
EP2654764B1 (en) 2016-02-24
CA2822251A1 (en) 2012-06-28
US10022410B2 (en) 2018-07-17
JP6000976B2 (ja) 2016-10-05
CN103260633A (zh) 2013-08-21
US20120164224A1 (en) 2012-06-28
TW201242606A (en) 2012-11-01
AU2011349659B2 (en) 2016-05-05
US20140017348A1 (en) 2014-01-16
EP2654764A1 (en) 2013-10-30
TWI584811B (zh) 2017-06-01
RU2013133931A (ru) 2015-01-27
WO2012087774A1 (en) 2012-06-28

Similar Documents

Publication Publication Date Title
SMT201700008B (it) Composizione farmaceutica
SMT201600350B (it) Composizioni farmaceutiche
BR112013002845A2 (pt) combinação de susbtâncias ativas
DK3246018T3 (da) Farmaceutisk sammensætning
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
CO6960555A2 (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
BR112013008359A2 (pt) composição de café concentrado
FR2968669B1 (fr) Composition de graisse
DK2654736T3 (da) Hidtil ukendt farmaceutisk sammensætning
FR2968670B1 (fr) Composition de graisse
EE201300005A (et) Ravimkoostis
FR2955770B1 (fr) Composition cosmetique.
FR2994831B1 (fr) Prothese de main.
BR112013016135A2 (pt) preparação hemostática contendo um extrato de cibotium barometz.
DK2635269T3 (da) Kombinationspræparat
BR112015023620A2 (pt) preparação de malto-oligossacarídeos.
CO6801722A2 (es) Composiciones farmacéuticas
BR112012028007A2 (pt) composição aquosa
ITTO20110268A1 (it) Composizione di maquillage.
IT1402120B1 (it) Composizione di malta.
DK2590565T3 (da) Blodprøvetagning
DK2655360T3 (da) Fremgangsmåde til fremstilling af n-sulfonylsubstituerede oxindoler
ITTO20111220A1 (it) Composizione contenente un fosfato di tocoferolo e procedimento di preparazione.
BR112012029461A2 (pt) composição farmacêutica contendo solifenacina
BR112013014819A2 (pt) composição extratora

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]